Loading clinical trials...
Loading clinical trials...
Transcatheter edge-to-edge repair of the mitral valve (M-TEER) is a well-established endovascular treatment option for patients with severe mitral regurgitation who are at high risk for surgery-relate...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Xiao-dong Zhuang
NCT04761120 · Mitral Regurgitation, Tricuspid Regurgitation, and more
NCT04688190 · Mitral Regurgitation, Mitral Valve Disease, and more
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT05061004 · Mitral Regurgitation
NCT07007143 · Mitral Regurgitation
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions